COVID-19 and effects on osteoporosis management: the patient perspective from a National Osteoporosis Foundation survey.

Singer, A J; Fuggle, N R; Gill, C B; Patel, A R; Medeiros, A P; Greenspan, S L

Singer, A J; Fuggle, N R; Gill, C B; Patel, A R; Medeiros, A P; Greenspan, S L.

Singer AJ; Departments of Medicine and Obstetrics and Gynecology, MedStar Georgetown University Hospital and Georgetown University Medical Center, Washington, DC, USA. andrea.f.singer@gunet.georgetown.edu.
Fuggle NR; Department of Obstetrics and Gynecology, MedStar Georgetown University Hospital, Washington, DC, USA. andrea.f.singer@gunet.georgetown.edu.
Gill CB; MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, UK.
Patel AR; Alan Turing Institute, London, UK.
Medeiros AP; National Osteoporosis Foundation, Arlington, VA, USA.
Greenspan SL; National Osteoporosis Foundation, Arlington, VA, USA.

Osteoporos Int ; 32(4): 619-622, 2021 04.

Article in English | MEDLINE | ID: covidwho-1070824

Subject(s)

COVID-19; Osteoporosis; Humans; Osteoporosis/drug therapy; SARS-CoV-2

Keywords

Bone health; COVID-19; Fracture; Osteoporosis; Telemedicine

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Osteoporosis / COVID-19 Type of study: Experimental Studies / Observational study Limits: Humans Language: English Journal: Osteoporos Int Journal subject: Metabolism / Orthopedics Year: 2021 Document Type: Article Affiliation country: S00198-021-05836-3

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google